Sometimes You Just Cannot Make This Stuff Up

08 June 2015 Labor & Employment Law Perspectives Blog

Warning: The following is true. Some readers may find the content disturbing. Reader discretion is advised.

We have previously stated, although in somewhat tongue-in-cheek fashion, that labor and employment is the “TMZ” of the legal world. While that metaphoric comparison may be open for debate, many human resources professionals and employment law practitioners know that we are great company at cocktail parties because of the stories we can tell (while, of course maintaining proper confidentiality). A recent decision by the federal district court in Atlanta not only provides the kind of fodder for such stories, but may also become notable as one of the first court interpretations of the Genetic Information Non-Disclosure Act (GINA) and leave an indelible mark on future interpretations of that law.

We noted years ago that GINA was one the newest areas of federal anti-discrimination focus, but as perhaps one of the least known anti-discrimination laws and one of the newest, there has, at least so far, been little court interpretation and guidance regarding the law. GINA prohibits the use of genetic information in making employment decisions and precludes employers from “requesting, requiring or purchasing” genetic information except in very limited circumstances. The recent federal case provides one of the first demonstrations of how the law will play out in the real world.

The facts of the recent case involve some dirty conduct on the part of employees in a warehouse and an employer’s attempt to flush out the wrongdoers. Lest you question whether we are exaggerating, we offer the following rundown of the facts, taken directly from the text of the court’s decision:

[The employer] operates warehouses for the storage of products sold at a variety of grocery stores. So one could imagine [the employer’s] frustration when a mystery employee began habitually defecating in one of its warehouses¹. To solve the mystery of the devious defecator, [the employer] requested some of its employees, including [Employee 1] and [Employee 2] to submit to a cheek swab. The cheek cell samples were then sent to a lab where a technician compared the cheek cell DNA to DNA from the offending fecal matter. [Employee 1] and [Employee 2] were not a match. With the culprit apparently still on the loose, [Employee 1] and [Employee 2] filed suit under the Genetic Information Nondiscrimination Act (“GINA”), 42 U.S.C. § 2000ff, et seq., which generally prohibits employers from requesting genetic information from its employees.

To identify the dastardly defecator, the company tasked its loss prevention manager with conducting an investigation. By matching employee assignments and the placement of the poop, the LP manager identified multiple suspects, who were each asked to submit to a test in which the inside of their cheeks (facial only) were wiped and their samples submitted for testing. Short tandem repeat (STR) analysis can be used to compare DNA from one sample (the cheek swabs) to another (the “sample”) for identification purposes.

Two employees whose cheek swab samples did not match the DNA found in the poop filed charges of discrimination with the EEOC. They contended that the company’s conduct violated GINA by illegally requiring the employees to provide their genetic information. In response, the employer argued that because STR analysis cannot determine an individual’s propensity for disease or disorder, it was not the type of test prohibited by GINA. The EEOC issued a Notice of Right to Sue, and the case plopped in front of a federal judge on cross motions for summary judgment.

The court rejected the employer’s argument that the tests did not constitute a request for genetic information within the meaning of GINA because the test performed can only be used for matching samples and not predicting one’s propensity for disease. Instead, the judge looked to the plain meaning of GINA, which among other things defines genetic test as “an analysis for human DNA, RNA, chromosomes, proteins or metabolites…” Clearly, the test mandated by the employer fell within this definition.

As all good stories do, this case should not only leave its mark in the memory of its readers, it also provides a valuable training moment. The lesson for employers with more than 15 employees is that GINA provides yet another legislative proscription which must be considered when hiring, monitoring, and investigating employee behavior. Genetic analysis is not the way to catch crappy employees, no matter how stinky the circumstances of employee misconduct may appear.


¹ Apparently, this problem is not as rare as one might imagine.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services

Insights

RCE PTA Carve-Out Resumes After Interference
18 September 2019
PharmaPatents
The Ninth Circuit Expected to Rule that Doctors Can Be Wrong in the Winter v. Gardens False Claims Act Case
18 September 2019
Legal News: Government Enforcement Defense & Investigations
Upcoming Webinar: Maximizing Solar Tax Credits - Navigating the Start of Construction Rules (Part 1)
17 September 2019
Renewable Energy Outlook
When Birds Finally Find a Nest
17 September 2019
Dashboard Insights
Lacktman, Ferrante Cited in mHealth Intelligence About Ryan Haight Act
19 September 2019
mHealth Intelligence
Tinnen Discusses How Viewpoint Diversity Helps Businesses Thrive
18 September 2019
InsideTrack
Vernaglia Comments on AHA v Azar Decision
18 September 2019
MedPage Today
Lach Comments on Launch of New Group
16 September 2019
BizTimes Milwaukee
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
BRG Healthcare Leadership Conference
06 December 2019
Washington, D.C.
CTeL Telehealth Fall Summit 2019
04-06 December 2019
Washington, D.C.